{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:19:30Z","timestamp":1790716770175,"version":"4.1.0"},"reference-count":157,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100008245","name":"Center for Neuroscience Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008257","name":"Tarbiat Modares University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008257","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017500","name":"Neuroscience Research Center, Shahid Beheshti University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017500","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020481","name":"Shahid Beheshti University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020481","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.pnpbp.2026.111848","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T23:39:04Z","timestamp":1784590744000},"page":"111848","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Unlocking new uses: The promise of antidepressants in treating Alzheimer's and Parkinson's through Neuroinflammation modulation"],"prefix":"10.1016","volume":"149","author":[{"given":"Fatemeh","family":"Abbaszadeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nahal Babaeian","family":"Amini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samin","family":"Davoody","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohsen","family":"Rezaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasoul","family":"Ghasemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pegah","family":"Javadpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2026.111848_bb0005","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s00580-014-1994-7","article-title":"Study of the effect of antidepressant drugs and donepezil on aluminum-induced memory impairment and biochemical alterations in rats","volume":"24","author":"Abdel-Salam","year":"2015","journal-title":"Comp. Clin. Pathol."},{"key":"10.1016\/j.pnpbp.2026.111848_bb0010","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.715354","article-title":"Rivaroxaban modulates TLR4\/Myd88\/NF-k\u03b2 signaling pathway in a dose-dependent manner with suppression of oxidative stress and inflammation in an experimental model of depression","volume":"12","author":"Abdelzaher","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.pnpbp.2026.111848_bb0015","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.brainresbull.2016.02.007","article-title":"Effects of 1-cyclohexyl-and 1-cyclohexyl-N-propargyl-1, 2, 3, 4-tetrahydroisoquinoline on dopaminergic spontaneous discharge in nigral neurons of rats","volume":"121","author":"Abe","year":"2016","journal-title":"Brain Res. Bull."},{"issue":"21","key":"10.1016\/j.pnpbp.2026.111848_bb0020","doi-asserted-by":"crossref","first-page":"6752","DOI":"10.3390\/molecules26216752","article-title":"Attenuative effects of fluoxetine and Triticum aestivum against aluminum-induced Alzheimer\u2019s disease in rats: the possible consequences on hepatotoxicity and nephrotoxicity","volume":"26","author":"Abu-Elfotuh","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.pnpbp.2026.111848_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.108488","article-title":"Fluoxetine ameliorates Alzheimer\u2019s disease progression and prevents the exacerbation of cardiovascular dysfunction of socially isolated depressed rats through activation of Nrf2\/HO-1 and hindering TLR4\/NLRP3 inflammasome signaling pathway","volume":"104","author":"Abu-Elfotuh","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.pnpbp.2026.111848_bb0030","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2024.1347987","article-title":"The role of neuroinflammation in neurodegenerative diseases: current understanding and future therapeutic targets","volume":"16","author":"Adamu","year":"2024","journal-title":"Front. Aging Neurosci."},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111848_bb0035","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s40035-020-00194-2","article-title":"Paroxetine ameliorates prodromal emotional dysfunction and late-onset memory deficit in Alzheimer\u2019s disease mice","volume":"9","author":"Ai","year":"2020","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.pnpbp.2026.111848_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2020.155100","article-title":"Inflammatory modulation of fluoxetine use in patients with depression: a systematic review and meta-analysis","volume":"131","author":"Almeida","year":"2020","journal-title":"Cytokine"},{"issue":"10","key":"10.1016\/j.pnpbp.2026.111848_bb0045","doi-asserted-by":"crossref","DOI":"10.3390\/cells9102265","article-title":"The multimodal serotonergic agent Vilazodone inhibits L-DOPA-induced gene regulation in striatal projection neurons and associated dyskinesia in an animal model of Parkinson\u2019s disease","volume":"9","author":"Altwal","year":"2020","journal-title":"Cells"},{"issue":"19","key":"10.1016\/j.pnpbp.2026.111848_bb0050","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26195790","article-title":"Role of 5-HT1A receptor in Vilazodone-mediated suppression of L-DOPA-induced dyskinesia and increased responsiveness to cortical input in striatal medium spiny neurons in an animal model of Parkinson\u2019s disease","volume":"26","author":"Altwal","year":"2021","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.pnpbp.2026.111848_bb0055","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/imm.12233","article-title":"Inflammation in neurodegenerative diseases\u2013an update","volume":"142","author":"Amor","year":"2014","journal-title":"Immunology"},{"issue":"18","key":"10.1016\/j.pnpbp.2026.111848_bb0060","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.3390\/cells11182908","article-title":"Neuroinflammation and Parkinson\u2019s disease\u2014from neurodegeneration to therapeutic opportunities","volume":"11","author":"Ara\u00fajo","year":"2022","journal-title":"Cells"},{"issue":"8","key":"10.1016\/j.pnpbp.2026.111848_bb0065","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s11910-022-01207-5","article-title":"Neurodegeneration and neuroinflammation in Parkinson\u2019s disease: a self-sustained loop","volume":"22","author":"Arena","year":"2022","journal-title":"Curr. Neurol. Neurosci. Rep."},{"issue":"2","key":"10.1016\/j.pnpbp.2026.111848_bb0070","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s12031-008-9139-6","article-title":"The novel cholinesterase-monoamine oxidase inhibitor and antioxidant, ladostigil, confers neuroprotection in neuroblastoma cells and aged rats","volume":"37","author":"Bar-Am","year":"2009","journal-title":"J. Mol. Neurosci."},{"issue":"3","key":"10.1016\/j.pnpbp.2026.111848_bb0075","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1124\/jpet.117.241653","article-title":"Sembragiline: a novel, selective monoamine oxidase type B inhibitor for the treatment of Alzheimer\u2019s disease","volume":"362","author":"Borroni","year":"2017","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111848_bb0080","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/s12974-022-02584-x","article-title":"Neuroinflammation represents a common theme amongst genetic and environmental risk factors for Alzheimer and Parkinson diseases","volume":"19","author":"Boyd","year":"2022","journal-title":"J. Neuroinflammation"},{"issue":"2","key":"10.1016\/j.pnpbp.2026.111848_bb0085","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1212\/WNL.44.2.227","article-title":"Inverse association of anti\u2013inflammatory treatments and Alzheimer\u2019s disease","volume":"44","author":"Breitner","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.pnpbp.2026.111848_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174073","article-title":"Differential impact of imipramine on thapsigargin- and tunicamycin-induced endoplasmic reticulum stress and mitochondrial dysfunction in neuroblastoma SH-SY5Y cells","volume":"902","author":"Brodnanova","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2026.111848_bb0095","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1007\/s11064-006-9249-x","article-title":"Antioxidant effects of selegiline in oxidative stress induced by iron neonatal treatment in rats","volume":"32","author":"Budni","year":"2007","journal-title":"Neurochem. Res."},{"issue":"6","key":"10.1016\/j.pnpbp.2026.111848_bb0100","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/j.1365-2710.2006.00778.x","article-title":"Long-term effects of antidepressants on cognition in patients with Alzheimer\u2019s disease","volume":"31","author":"Caballero","year":"2006","journal-title":"J. Clin. Pharm. Ther."},{"key":"10.1016\/j.pnpbp.2026.111848_bb0105","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.809541","article-title":"Antioxidant activity of fluoxetine and vortioxetine in a non-transgenic animal model of alzheimer\u2019s disease","volume":"12","author":"Caruso","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"6","key":"10.1016\/j.pnpbp.2026.111848_bb0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0021660","article-title":"Amitriptyline-mediated cognitive enhancement in aged 3\u00d7Tg Alzheimer\u2019s disease mice is associated with neurogenesis and neurotrophic activity","volume":"6","author":"Chadwick","year":"2011","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.pnpbp.2026.111848_bb0115","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1124\/jpet.109.162164","article-title":"Imipramine, in part through tumor necrosis factor alpha inhibition, prevents cognitive decline and beta-amyloid accumulation in a mouse model of Alzheimer\u2019s disease","volume":"332","author":"Chavant","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pnpbp.2026.111848_bb0120","series-title":"StatPearls","article-title":"Selective serotonin reuptake inhibitors","author":"Chu","year":"2023"},{"key":"10.1016\/j.pnpbp.2026.111848_bb0125","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.brainres.2010.09.049","article-title":"Fluoxetine prevents LPS-induced degeneration of nigral dopaminergic neurons by inhibiting microglia-mediated oxidative stress","volume":"1363","author":"Chung","year":"2010","journal-title":"Brain Res."},{"issue":"2","key":"10.1016\/j.pnpbp.2026.111848_bb0130","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.4049\/jimmunol.1000208","article-title":"Paroxetine prevents loss of nigrostriatal dopaminergic neurons by inhibiting brain inflammation and oxidative stress in an experimental model of Parkinson\u2019s disease","volume":"185","author":"Chung","year":"2010","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.pnpbp.2026.111848_bb0135","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.neuropharm.2011.01.043","article-title":"Fluoxetine prevents MPTP-induced loss of dopaminergic neurons by inhibiting microglial activation","volume":"60","author":"Chung","year":"2011","journal-title":"Neuropharmacology"},{"issue":"8","key":"10.1016\/j.pnpbp.2026.111848_bb0140","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1002\/jnr.23577","article-title":"1-[2-(4-Benzyloxyphenoxy) ethyl] imidazole inhibits monoamine oxidase B and protects against neuronal loss and behavioral impairment in rodent models of Parkinson\u2019s disease","volume":"93","author":"Chung","year":"2015","journal-title":"J. Neurosci. Res."},{"issue":"19","key":"10.1016\/j.pnpbp.2026.111848_bb0145","doi-asserted-by":"crossref","first-page":"e2666","DOI":"10.1212\/WNL.0000000000010733","article-title":"Effect of escitalopram on A\u03b2 levels and plaque load in an Alzheimer mouse model","volume":"95","author":"Cirrito","year":"2020","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.pnpbp.2026.111848_bb0150","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1074\/jbc.M114.588608","article-title":"Amitriptyline improves motor function via enhanced neurotrophin signaling and mitochondrial functions in the murine N171-82Q Huntington disease model","volume":"290","author":"Cong","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pnpbp.2026.111848_bb0155","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.pbb.2016.01.004","article-title":"Effect of tricyclic antidepressants on L-DOPA-induced dyskinesia and motor improvement in hemi-parkinsonian rats","volume":"142","author":"Conti","year":"2016","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"5","key":"10.1016\/j.pnpbp.2026.111848_bb0160","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1007\/s12035-018-1306-3","article-title":"Crosstalk between inflammation and glutamate system in depression: signaling pathway and molecular biomarkers for ketamine\u2019s antidepressant effect","volume":"56","author":"Cui","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.pnpbp.2026.111848_bb0165","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.bbr.2016.08.005","article-title":"Fluvoxamine maleate normalizes striatal neuronal inflammatory cytokine activity in a parkinsonian rat model associated with depression","volume":"316","author":"Dall\u00e9","year":"2017","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pnpbp.2026.111848_bb0170","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/1941480","article-title":"Long-term treatment with fluvoxamine decreases nonmotor symptoms and dopamine depletion in a postnatal stress rat model of Parkinson\u2019s disease","volume":"2020","author":"Dall\u00e9","year":"2020","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111848_bb0175","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.expneurol.2005.07.017","article-title":"Selegiline protects against recognition memory impairment induced by neonatal iron treatment","volume":"196","author":"de Lima","year":"2005","journal-title":"Exp. Neurol."},{"issue":"9","key":"10.1016\/j.pnpbp.2026.111848_bb0180","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1111\/j.1460-9568.2005.04083.x","article-title":"Recognition memory impairment and brain oxidative stress induced by postnatal iron administration","volume":"21","author":"De Lima","year":"2005","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.pnpbp.2026.111848_bb0185","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s10787-020-00777-5","article-title":"The anti-inflammatory role of SSRI and SNRI in the treatment of depression: a review of human and rodent research studies","volume":"29","author":"Dionisie","year":"2021","journal-title":"Inflammopharmacology"},{"issue":"6","key":"10.1016\/j.pnpbp.2026.111848_bb0190","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1111\/jgs.12838","article-title":"Effect of medications on physical function and cognition in nursing home residents with dementia","volume":"62","author":"Dutcher","year":"2014","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.pnpbp.2026.111848_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2022.109841","article-title":"Modulation of histone deacetylase, the ubiquitin proteasome system, and autophagy underlies the neuroprotective effects of venlafaxine in a rotenone-induced Parkinson\u2019s disease model in rats","volume":"354","author":"El-Saiy","year":"2022","journal-title":"Chem. Biol. Interact."},{"issue":"2","key":"10.1016\/j.pnpbp.2026.111848_bb0200","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3390\/ph18020197","article-title":"The anti-inflammatory potential of tricyclic antidepressants (TCAs): a novel therapeutic approach to atherosclerosis pathophysiology","volume":"18","author":"Eslami","year":"2025","journal-title":"Pharmaceuticals"},{"issue":"5","key":"10.1016\/j.pnpbp.2026.111848_bb0205","doi-asserted-by":"crossref","first-page":"508","DOI":"10.2174\/1570159X15666170720095240","article-title":"Microglia and astrocytes in Alzheimer\u2019s disease: implications for therapy","volume":"16","author":"Fakhoury","year":"2018","journal-title":"Curr. Neuropharmacol."},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111848_bb0210","doi-asserted-by":"crossref","first-page":"81","DOI":"10.4103\/amhs.amhs_7_18","article-title":"Neuropharmacological classification of antidepressant agents based on their mechanisms of action","volume":"6","author":"Fasipe","year":"2018","journal-title":"Arch. Med. Health Sci."},{"issue":"5","key":"10.1016\/j.pnpbp.2026.111848_bb0215","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1046\/j.1460-9568.2000.00044.x","article-title":"MPTP selectively induces haem oxygenase-1 expression in striatal astrocytes","volume":"12","author":"Fernandez-Gonzalez","year":"2000","journal-title":"Eur. J. Neurosci."},{"issue":"12","key":"10.1016\/j.pnpbp.2026.111848_bb0220","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1002\/acn3.369","article-title":"Genomics implicates adaptive and innate immunity in Alzheimer\u2019s and Parkinson\u2019s diseases","volume":"3","author":"Gagliano","year":"2016","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.pnpbp.2026.111848_bb0225","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s12640-009-9070-9","article-title":"Restoration of nigrostriatal dopamine neurons in post-MPTP treatment by the novel multifunctional brain-permeable iron chelator-monoamine oxidase inhibitor drug, M30","volume":"17","author":"Gal","year":"2010","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.pnpbp.2026.111848_bb0230","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.pnpbp.2017.03.016","article-title":"The anti-inflammatory mechanism of antidepressants\u2013SSRIs, SNRIs","volume":"80","author":"Ga\u0142ecki","year":"2018","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111848_bb0235","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13195-015-0126-1","article-title":"Post-mortem analysis of neuroinflammatory changes in human Alzheimer\u2019s disease","volume":"7","author":"Gomez-Nicola","year":"2015","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"10.1016\/j.pnpbp.2026.111848_bb0240","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jad.2019.05.009","article-title":"Involvement of the microglial NLRP3 inflammasome in the anti-inflammatory effect of the antidepressant clomipramine","volume":"254","author":"Gong","year":"2019","journal-title":"J. Affect. Disord."},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111848_bb0245","article-title":"Neuroprotective effects of meloxicam and selegiline in scopolamine-induced cognitive impairment and oxidative stress","volume":"2012","author":"Goverdhan","year":"2012","journal-title":"Int. J. Alzheimers Dis."},{"issue":"19","key":"10.1016\/j.pnpbp.2026.111848_bb0250","doi-asserted-by":"crossref","first-page":"7611","DOI":"10.1073\/pnas.86.19.7611","article-title":"Brain interleukin 1 and S-100 immunoreactivity are elevated in down syndrome and Alzheimer disease","volume":"86","author":"Griffin","year":"1989","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111848_bb0255","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/ibra.12023","article-title":"The role of microglia in Alzheimer\u2019s disease and progress of treatment","volume":"8","author":"Guan","year":"2022","journal-title":"Ibrain"},{"issue":"12","key":"10.1016\/j.pnpbp.2026.111848_bb0260","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1038\/npp.2011.132","article-title":"The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis","volume":"36","author":"Hannestad","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2026.111848_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.exger.2024.112517","article-title":"Effect of imipramine on memory, adult neurogenesis, neuroinflammation, and mitochondrial biogenesis in a rat model of alzheimer\u2019s disease","volume":"194","author":"Hasanabadi","year":"2024","journal-title":"Exp. Gerontol."},{"issue":"4","key":"10.1016\/j.pnpbp.2026.111848_bb0270","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","article-title":"Neuroinflammation in Alzheimer\u2019s disease","volume":"14","author":"Heneka","year":"2015","journal-title":"Lancet Neurol."},{"issue":"6","key":"10.1016\/j.pnpbp.2026.111848_bb0275","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1007\/s00401-003-0766-2","article-title":"Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson\u2019s disease brains","volume":"106","author":"Imamura","year":"2003","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.pnpbp.2026.111848_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2021.113260","article-title":"Imipramine alleviates memory impairment and hippocampal apoptosis in STZ-induced sporadic Alzheimer\u2019s rat model: possible contribution of MAPKs and insulin signaling","volume":"408","author":"Javadpour","year":"2021","journal-title":"Behav. Brain Res."},{"issue":"9","key":"10.1016\/j.pnpbp.2026.111848_bb0285","doi-asserted-by":"crossref","first-page":"7151","DOI":"10.1007\/s12035-024-04009-7","article-title":"Mitochondrial transportation, transplantation, and subsequent immune response in Alzheimer\u2019s disease: an update","volume":"61","author":"Javadpour","year":"2024","journal-title":"Mol. Neurobiol."},{"issue":"8","key":"10.1016\/j.pnpbp.2026.111848_bb0290","doi-asserted-by":"crossref","first-page":"529","DOI":"10.3923\/ijp.2020.529.541","article-title":"Neuroprotective effects of co-Administration of Selegiline with Piracetam on cognitive impairment: involvement of NR2B, NR1 and Bax signaling pathway","volume":"16","author":"Jawaid","year":"2020","journal-title":"Int. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.pnpbp.2026.111848_bb0295","first-page":"87","article-title":"Lornoxicam alone and with selegiline improves the neuroprotective effect and cognition in scopolamine induced neurodegeneration and cognitive impairment in rats: neuroprotective effect of lornoxicam and selegiline","volume":"9","author":"Sainath Reddy","year":"2013","journal-title":"Iran. J. Pharm. Sci."},{"issue":"18","key":"10.1016\/j.pnpbp.2026.111848_bb0300","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.ibneur.2025.05.005","article-title":"Effect of neuroinflammation on the progression of Alzheimer\u2019s disease and its significant ramifications for novel anti-inflammatory treatments","volume":"22","author":"Kamila","year":"2025","journal-title":"IBRO Neurosci Rep."},{"key":"10.1016\/j.pnpbp.2026.111848_bb0305","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.neuint.2018.10.004","article-title":"Interactions of the tricyclic antidepressant drug amitriptyline with L-DOPA in the striatum and substantia nigra of unilaterally 6-OHDA-lesioned rats. Relevance to motor dysfunction in Parkinson\u2019s disease","volume":"121","author":"Kami\u0144ska","year":"2018","journal-title":"Neurochem. Int."},{"issue":"11","key":"10.1016\/j.pnpbp.2026.111848_bb0310","doi-asserted-by":"crossref","first-page":"3633","DOI":"10.1007\/s00213-022-06238-x","article-title":"Behavioral and neurochemical interactions of the tricyclic antidepressant drug desipramine with L-DOPA in 6-OHDA-lesioned rats. Implications for motor and psychiatric functions in Parkinson's disease","volume":"239","author":"Kami\u0144ska","year":"2022","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2026.111848_bb0315","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.neuroscience.2016.06.040","article-title":"Imipramine and amitriptyline ameliorate the rotenone model of Parkinson\u2019s disease in rats","volume":"332","author":"Kandil","year":"2016","journal-title":"Neuroscience"},{"key":"10.1016\/j.pnpbp.2026.111848_bb0320","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s13346-019-00625-2","article-title":"Polycaprolactone-based neurotherapeutic delivery of rasagiline targeting behavioral and biochemical deficits in Parkinson\u2019s disease","volume":"9","author":"Kanwar","year":"2019","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.pnpbp.2026.111848_bb0325","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jns.2017.08.3251","article-title":"Neuroinflammation-a major cause for striatal dopaminergic degeneration in Parkinson\u2019s disease","volume":"381","author":"Kaur","year":"2017","journal-title":"J. Neurol. Sci."},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111848_bb0330","article-title":"Neuroinflammation induces neurodegeneration","volume":"1","author":"Kempuraj","year":"2016","journal-title":"J. Neurol. Neurosurg. Spine"},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111848_bb0335","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s40263-018-0590-9","article-title":"Impact of antidepressant use on the trajectory of Alzheimer\u2019s disease: evidence, mechanisms, and therapeutic implications","volume":"33","author":"Khoury","year":"2019","journal-title":"CNS Drugs"},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111848_bb0340","article-title":"Norfluoxetine prevents degeneration of dopamine neurons by inhibiting microglia-derived oxidative stress in an MPTP mouse model of Parkinson\u2019s disease","volume":"2018","author":"Kim","year":"2018","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.pnpbp.2026.111848_bb0345","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.trci.2018.06.014","article-title":"Inflammation as a central mechanism in Alzheimer\u2019s disease","volume":"4","author":"Kinney","year":"2018","journal-title":"Alzheimers Dement. (N Y)."},{"key":"10.1016\/j.pnpbp.2026.111848_bb0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2021.128051","article-title":"Novel 1-(prop-2-yn-1-ylamino)-2, 3-dihydro-1H-indene-4-thiol derivatives as potent selective human monoamine oxidase B inhibitors: design, SAR development, and biological evaluation","volume":"43","author":"Kong","year":"2021","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"9","key":"10.1016\/j.pnpbp.2026.111848_bb0355","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.3390\/brainsci12091237","article-title":"Alzheimer\u2019s disease and inflammaging","volume":"12","author":"Kosyreva","year":"2022","journal-title":"Brain Sci."},{"issue":"6","key":"10.1016\/j.pnpbp.2026.111848_bb0360","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1089\/ars.2011.4279","article-title":"The novel multi-target iron chelating-radical scavenging compound M30 possesses beneficial effects on major hallmarks of Alzheimer\u2019s disease","volume":"17","author":"Kupershmidt","year":"2012","journal-title":"Antioxid. Redox Signal."},{"issue":"10","key":"10.1016\/j.pnpbp.2026.111848_bb0365","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1038\/s41419-020-03085-6","article-title":"Amitriptyline interferes with autophagy-mediated clearance of protein aggregates via inhibiting autophagosome maturation in neuronal cells","volume":"11","author":"Kwon","year":"2020","journal-title":"Cell Death Dis."},{"issue":"5","key":"10.1016\/j.pnpbp.2026.111848_bb0370","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s00702-017-1731-x","article-title":"In vivo PET imaging of neuroinflammation in Alzheimer\u2019s disease","volume":"125","author":"Lagarde","year":"2018","journal-title":"J. Neural Transm. (Vienna)"},{"issue":"8","key":"10.1016\/j.pnpbp.2026.111848_bb0375","first-page":"734","article-title":"Tricyclic antidepressants amitriptyline and Desipramine induced neurotoxicity associated with Parkinson\u2019s disease","volume":"38","author":"Lee","year":"2015","journal-title":"Mol. Cell"},{"issue":"10","key":"10.1016\/j.pnpbp.2026.111848_bb0380","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1093\/gerona\/glx226","article-title":"Antidepressant use and cognitive outcomes in very old women","volume":"73","author":"Leng","year":"2018","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"issue":"3","key":"10.1016\/j.pnpbp.2026.111848_bb0385","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0300-483X(01)00541-8","article-title":"Deprenyl protects from MPTP-induced Parkinson-like syndrome and glutathione oxidation in rat striatum","volume":"170","author":"Leret","year":"2002","journal-title":"Toxicology"},{"issue":"4","key":"10.1016\/j.pnpbp.2026.111848_bb0390","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1038\/s41380-023-02399-z","article-title":"Iron imbalance in neurodegeneration","volume":"29","author":"Levi","year":"2024","journal-title":"Mol. Psychiatry"},{"issue":"7638","key":"10.1016\/j.pnpbp.2026.111848_bb0395","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature21029","article-title":"Neurotoxic reactive astrocytes are induced by activated microglia","volume":"541","author":"Liddelow","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.pnpbp.2026.111848_bb0400","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1742-2094-11-47","article-title":"Paroxetine ameliorates lipopolysaccharide-induced microglia activation via differential regulation of MAPK signaling","volume":"11","author":"Liu","year":"2014","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.pnpbp.2026.111848_bb0405","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.neuropharm.2016.06.013","article-title":"Design, synthesis and evaluation of novel dual monoamine-cholinesterase inhibitors as potential treatment for Alzheimer\u2019s disease","volume":"109","author":"Liu","year":"2016","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.pnpbp.2026.111848_bb0410","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1007\/s12031-017-0891-3","article-title":"Neuroprotective effects and mechanisms of action of multifunctional agents targeting free radicals, monoamine oxidase B and cholinesterase in Parkinson\u2019s disease model","volume":"61","author":"Liu","year":"2017","journal-title":"J. Mol. Neurosci."},{"issue":"2","key":"10.1016\/j.pnpbp.2026.111848_bb0415","first-page":"149","article-title":"Fluoxetine improves the effect of levodopa on 6-hydroxy dopamine-induced motor impairments in rats","volume":"2","author":"Mahmoudi","year":"2012","journal-title":"Adv. Pharm. Bull."},{"issue":"22","key":"10.1016\/j.pnpbp.2026.111848_bb0420","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21228421","article-title":"Neurodegeneration and inflammation-an interesting interplay in Parkinson\u2019s disease","volume":"21","author":"Marogianni","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.pnpbp.2026.111848_bb0425","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/mds.21751","article-title":"Glial reactions in Parkinson\u2019s disease","volume":"23","author":"McGeer","year":"2008","journal-title":"Mov. Disord."},{"issue":"8","key":"10.1016\/j.pnpbp.2026.111848_bb0430","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1212\/WNL.38.8.1285","article-title":"Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson\u2019s and Alzheimer\u2019s disease brains","volume":"38","author":"McGeer","year":"1988","journal-title":"Neurology"},{"key":"10.1016\/j.pnpbp.2026.111848_bb0435","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.108415","article-title":"Metformin and fluoxetine improve depressive-like behavior in a murine model of Parkinso\u0144s disease through the modulation of neuroinflammation, neurogenesis and neuroplasticity","volume":"102","author":"Mendon\u00e7a","year":"2022","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111848_bb0440","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/msj.20163","article-title":"Relationship between tau pathology and neuroinflammation in Alzheimer\u2019s disease","volume":"77","author":"Metcalfe","year":"2010","journal-title":"Mt. Sinai J. Med."},{"issue":"6","key":"10.1016\/j.pnpbp.2026.111848_bb0445","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.3599","article-title":"Protective effects of selegiline against amyloid beta-induced anxiety-like behavior and memory impairment","volume":"14","author":"Mohamadpour","year":"2024","journal-title":"Brain Behav."},{"issue":"4\u20135","key":"10.1016\/j.pnpbp.2026.111848_bb0450","first-page":"131","article-title":"Comparison of sertraline, venlafaxine and desipramine effects on depression, cognition and the daily living activities in Alzheimer patients","volume":"47","author":"Mokhber","year":"2014","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.pnpbp.2026.111848_bb0455","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.pbb.2013.01.019","article-title":"Vortioxetine (Lu AA21004), a novel multimodal antidepressant, enhances memory in rats","volume":"105","author":"M\u00f8rk","year":"2013","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"4","key":"10.1016\/j.pnpbp.2026.111848_bb0460","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1159\/000121334","article-title":"Is antidepressant treatment associated with reduced cognitive decline in Alzheimer\u2019s disease?","volume":"25","author":"Mossello","year":"2008","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.pnpbp.2026.111848_bb0465","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.108977","article-title":"Vortioxetine ameliorates motor and cognitive impairments in the rotenone-induced Parkinson's disease via targeting TLR-2 mediated neuroinflammation","volume":"208","author":"Nemutlu Samur","year":"2022","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.pnpbp.2026.111848_bb0470","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1177\/02698811221144636","article-title":"Role of serotonin in modulation of decision-making in Parkinson\u2019s disease","volume":"37","author":"Nobis","year":"2023","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2026.111848_bb0475","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.neuint.2019.02.003","article-title":"The vagus nerve role in antidepressants action: efferent vagal pathways participate in peripheral anti-inflammatory effect of fluoxetine","volume":"125","author":"Ondicova","year":"2019","journal-title":"Neurochem. Int."},{"issue":"5","key":"10.1016\/j.pnpbp.2026.111848_bb0480","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/WNF.0b013e3180616570","article-title":"Selegiline orally disintegrating tablets in patients with Parkinson disease and \u201cwearing off\u201d symptoms","volume":"30","author":"Ondo","year":"2007","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.pnpbp.2026.111848_bb0485","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112715","article-title":"Escitalopram moderately outperforms citalopram towards anti-neuroinflammation and neuroprotection in 6-hydroxydopamine-induced mouse model of Parkinson\u2019s disease","volume":"139","author":"Ovlyakulov","year":"2024","journal-title":"Int. Immunopharmacol."},{"issue":"7","key":"10.1016\/j.pnpbp.2026.111848_bb0490","doi-asserted-by":"crossref","DOI":"10.3390\/cells9071687","article-title":"Inflammation in Parkinson\u2019s disease: mechanisms and therapeutic implications","volume":"9","author":"Pajares","year":"2020","journal-title":"Cells"},{"issue":"9","key":"10.1016\/j.pnpbp.2026.111848_bb0495","doi-asserted-by":"crossref","DOI":"10.3390\/cells9091982","article-title":"The MAO inhibitor tranylcypromine alters LPS- and a\u03b2-mediated Neuroinflammatory responses in wild-type mice and a mouse model of AD","volume":"9","author":"Park","year":"2020","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111848_bb0500","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3390\/antiox11010157","article-title":"The interconnected mechanisms of oxidative stress and neuroinflammation in epilepsy","volume":"11","author":"Parsons","year":"2022","journal-title":"Antioxidants"},{"issue":"22","key":"10.1016\/j.pnpbp.2026.111848_bb0505","doi-asserted-by":"crossref","first-page":"13954","DOI":"10.3390\/ijms232213954","article-title":"Alzheimer\u2019s disease: treatment strategies and their limitations","volume":"23","author":"Passeri","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.pnpbp.2026.111848_bb0510","doi-asserted-by":"crossref","first-page":"4188","DOI":"10.18632\/aging.101716","article-title":"Fluoxetine-mediated inhibition of endoplasmic reticulum stress is involved in the neuroprotective effects of Parkinson's disease","volume":"10","author":"Peng","year":"2018","journal-title":"Aging (Albany NY)"},{"issue":"9","key":"10.1016\/j.pnpbp.2026.111848_bb0515","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1038\/npp.2015.69","article-title":"Fluoxetine administration exacerbates Oral tremor and striatal dopamine depletion in a rodent pharmacological model of parkinsonism","volume":"40","author":"Podurgiel","year":"2015","journal-title":"Neuropsychopharmacology"},{"issue":"8","key":"10.1016\/j.pnpbp.2026.111848_bb0520","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.jpsychires.2008.10.006","article-title":"Macrophage migration inhibitory factor in mild cognitive impairment and Alzheimer\u2019s disease","volume":"43","author":"Popp","year":"2009","journal-title":"J. Psychiatr. Res."},{"issue":"7","key":"10.1016\/j.pnpbp.2026.111848_bb0525","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1001\/jama.2014.93","article-title":"Effect of citalopram on agitation in Alzheimer disease: the CitAD randomized clinical trial","volume":"311","author":"Porsteinsson","year":"2014","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.pnpbp.2026.111848_bb0530","first-page":"977","article-title":"Fluvoxamine inhibits some inflammatory genes expression in LPS\/stimulated human endothelial cells, U937 macrophages, and carrageenan-induced paw edema in rat","volume":"19","author":"Rafiee","year":"2016","journal-title":"Iran. J. Basic Med. Sci."},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111848_bb0535","doi-asserted-by":"crossref","first-page":"11","DOI":"10.37349\/ent.2024.00068","article-title":"Resolving a paradox: antidepressants, neuroinflammation, and neurodegeneration","volume":"4","author":"Rajkumar","year":"2024","journal-title":"Explor. Neuroprotective Ther."},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111848_bb0540","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/00002826-200201000-00004","article-title":"The SSRI, citalopram, improves bradykinesia in patients with Parkinson\u2019s disease treated with L-dopa","volume":"25","author":"Rampello","year":"2002","journal-title":"Clin. Neuropharmacol."},{"issue":"6301","key":"10.1016\/j.pnpbp.2026.111848_bb0545","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1126\/science.aag2590","article-title":"How neuroinflammation contributes to neurodegeneration","volume":"353","author":"Ransohoff","year":"2016","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111848_bb0550","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1176\/ajp.146.1.45","article-title":"Double-blind trial of imipramine in Alzheimer\u2019s disease patients with and without depression","volume":"146","author":"Reifler","year":"1989","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2026.111848_bb0555","article-title":"Anticholinergic drugs and risk of dementia: case-control study","volume":"361","author":"Richardson","year":"2018","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111848_bb0560","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1017\/S1041610209990184","article-title":"Efficacy of SSRIs on cognition of Alzheimer\u2019s disease patients treated with cholinesterase inhibitors","volume":"22","author":"Rozzini","year":"2010","journal-title":"Int. Psychogeriatr."},{"key":"10.1016\/j.pnpbp.2026.111848_bb0565","doi-asserted-by":"crossref","first-page":"862","DOI":"10.3389\/fnins.2019.00862","article-title":"Neuronal Sigma-1 receptors: signaling functions and protective roles in neurodegenerative diseases","volume":"13","author":"Ryskamp","year":"2019","journal-title":"Front. Neurosci."},{"issue":"4","key":"10.1016\/j.pnpbp.2026.111848_bb0570","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/00002826-200107000-00010","article-title":"Amoxapine shows an antipsychotic effect but worsens motor function in patients with Parkinson\u2019s disease and psychosis","volume":"24","author":"Sa","year":"2001","journal-title":"Clin. Neuropharmacol."},{"issue":"17","key":"10.1016\/j.pnpbp.2026.111848_bb0575","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1056\/NEJM199704243361704","article-title":"A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer\u2019s disease","volume":"336","author":"Sano","year":"1997","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111848_bb0580","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.neuint.2005.12.016","article-title":"L-deprenyl protects against rotenone-induced, oxidative stress-mediated dopaminergic neurodegeneration in rats","volume":"49","author":"Saravanan","year":"2006","journal-title":"Neurochem. Int."},{"issue":"6","key":"10.1016\/j.pnpbp.2026.111848_bb0585","doi-asserted-by":"crossref","first-page":"708","DOI":"10.3390\/pharmaceutics16060708","article-title":"Drug development for Alzheimer\u2019s and Parkinson\u2019s disease: where do we go now?","volume":"16","author":"Sequeira","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.pnpbp.2026.111848_bb0590","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.trci.2018.04.005","article-title":"Established amyloid-\u03b2 pathology is unaffected by chronic treatment with the selective serotonin reuptake inhibitor paroxetine","volume":"4","author":"Severino","year":"2018","journal-title":"Alzheimers Dement (N Y)"},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111848_bb0595","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1007\/s12035-016-0342-0","article-title":"Neuroprotective effects of antidepressants via upregulation of neurotrophic factors in the MPTP model of Parkinson\u2019s disease","volume":"55","author":"Shadfar","year":"2018","journal-title":"Mol. Neurobiol."},{"issue":"4","key":"10.1016\/j.pnpbp.2026.111848_bb0600","doi-asserted-by":"crossref","first-page":"491","DOI":"10.15171\/apb.2015.067","article-title":"Effect of Buspirone, fluoxetine and 8-OH-DPAT on striatal expression of Bax, Caspase-3 and Bcl-2 proteins in 6-Hydroxydopamine-induced hemi-parkinsonian rats","volume":"5","author":"Sharifi","year":"2015","journal-title":"Adv. Pharm. Bull."},{"issue":"8","key":"10.1016\/j.pnpbp.2026.111848_bb0605","first-page":"393","article-title":"Effect of chronic administration of buspirone and fluoxetine on inflammatory cytokines in 6-Hydroxydopamine-lesioned rats","volume":"65","author":"Sharifi","year":"2015","journal-title":"Drug Res. (Stuttg)"},{"key":"10.1016\/j.pnpbp.2026.111848_bb0610","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2020.172892","article-title":"Long-term exposure to constant light induces dementia, oxidative stress and promotes aggregation of sub-pathological A\u03b242 in Wistar rats","volume":"192","author":"Sharma","year":"2020","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"2","key":"10.1016\/j.pnpbp.2026.111848_bb0615","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.pathophys.2016.03.002","article-title":"Beneficial effect of antidepressants against rotenone induced parkinsonism like symptoms in rats","volume":"23","author":"Sharma","year":"2016","journal-title":"Pathophysiology"},{"issue":"12","key":"10.1016\/j.pnpbp.2026.111848_bb0620","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1021\/acschemneuro.1c00238","article-title":"Neuroprotective effects of fluoxetine on molecular markers of circadian rhythm, cognitive deficits, oxidative damage, and biomarkers of Alzheimer\u2019s disease-like pathology induced under chronic constant light regime in Wistar rats","volume":"12","author":"Sharma","year":"2021","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.pnpbp.2026.111848_bb0625","series-title":"StatPearls","article-title":"Antidepressants","author":"Sheffler","year":"2023"},{"key":"10.1016\/j.pnpbp.2026.111848_bb0630","doi-asserted-by":"crossref","first-page":"6251","DOI":"10.1007\/s12035-015-9527-1","article-title":"N-methyl, N-propynyl-2-phenylethylamine (MPPE), a selegiline analog, attenuates MPTP-induced dopaminergic toxicity with guaranteed behavioral safety: involvement of inhibitions of mitochondrial oxidative burdens and p53 gene-elicited pro-apoptotic change","volume":"53","author":"Shin","year":"2016","journal-title":"Mol. Neurobiol."},{"issue":"3","key":"10.1016\/j.pnpbp.2026.111848_bb0635","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.neuropharm.2006.10.005","article-title":"Ladostigil prevents gliosis, oxidative-nitrative stress and memory deficits induced by intracerebroventricular injection of streptozotocin in rats","volume":"52","author":"Shoham","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2026.111848_bb0640","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s00702-014-1307-y","article-title":"Brain catalase in the streptozotocin-rat model of sporadic Alzheimer\u2019s disease treated with the iron chelator\u2013monoamine oxidase inhibitor, M30","volume":"122","author":"Sofic","year":"2015","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.pnpbp.2026.111848_bb0645","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.105623","article-title":"6-Benzyloxyphthalides as selective and reversible monoamine oxidase B inhibitors with antioxidant and anti-neuroinflammatory activities for Parkinson\u2019s disease treatment","volume":"120","author":"Song","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.pnpbp.2026.111848_bb0650","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00702-005-0309-1","article-title":"Effects of selegiline on antioxidant systems in the nigrostriatum in rat","volume":"113","author":"Takahata","year":"2006","journal-title":"J. Neural Transm."},{"issue":"8","key":"10.1016\/j.pnpbp.2026.111848_bb0655","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s12149-016-1099-2","article-title":"Extrastriatal spreading of microglial activation in Parkinson\u2019s disease: a positron emission tomography study","volume":"30","author":"Terada","year":"2016","journal-title":"Ann. Nucl. Med."},{"issue":"11","key":"10.1016\/j.pnpbp.2026.111848_bb0660","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1097\/00001756-199808030-00031","article-title":"L-deprenyl: nitric oxide production and dilation of cerebral blood vessels","volume":"9","author":"Thomas","year":"1998","journal-title":"Neuroreport"},{"key":"10.1016\/j.pnpbp.2026.111848_bb0665","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2020.147261","article-title":"Protriptyline improves spatial memory and reduces oxidative damage by regulating NF\u03baB-BDNF\/CREB signaling axis in streptozotocin-induced rat model of Alzheimer\u2019s disease","volume":"1754","author":"Tiwari","year":"2021","journal-title":"Brain Res."},{"issue":"5","key":"10.1016\/j.pnpbp.2026.111848_bb0670","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S1474-4422(21)00030-2","article-title":"Challenges in the diagnosis of Parkinson\u2019s disease","volume":"20","author":"Tolosa","year":"2021","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.pnpbp.2026.111848_bb0675","doi-asserted-by":"crossref","first-page":"693","DOI":"10.3389\/fphar.2019.00693","article-title":"Fluoxetine and Vortioxetine reverse depressive-like phenotype and memory deficits induced by A\u03b2(1-42) oligomers in mice: a key role of transforming growth factor-\u03b21","volume":"10","author":"Torrisi","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.pnpbp.2026.111848_bb0680","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.bbi.2011.12.011","article-title":"A comparative examination of the anti-inflammatory effects of SSRI and SNRI antidepressants on LPS stimulated microglia","volume":"26","author":"Tynan","year":"2012","journal-title":"Brain Behav. Immun."},{"issue":"2","key":"10.1016\/j.pnpbp.2026.111848_bb0685","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.expneurol.2012.01.008","article-title":"Fluoxetine ameliorates behavioral and neuropathological deficits in a transgenic model mouse of \u03b1-synucleinopathy","volume":"234","author":"Ubhi","year":"2012","journal-title":"Exp. Neurol."},{"issue":"2","key":"10.1016\/j.pnpbp.2026.111848_bb0690","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1142\/S021963521650014X","article-title":"Desipramine improves depression-like behavior and working memory by up-regulating p-CREB in Alzheimer\u2019s disease associated mice","volume":"15","author":"Wang","year":"2016","journal-title":"J. Integr. Neurosci."},{"issue":"12","key":"10.1016\/j.pnpbp.2026.111848_bb0695","doi-asserted-by":"crossref","first-page":"13328","DOI":"10.18632\/oncotarget.7798","article-title":"Escitalopram attenuates \u03b2-amyloid-induced tau hyperphosphorylation in primary hippocampal neurons through the 5-HT1A receptor mediated Akt\/GSK-3\u03b2 pathway","volume":"7","author":"Wang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.pnpbp.2026.111848_bb0700","doi-asserted-by":"crossref","DOI":"10.1177\/1744806917691525","article-title":"Attenuation of hyperalgesia responses via the modulation of 5-hydroxytryptamine signalings in the rostral ventromedial medulla and spinal cord in a 6-hydroxydopamine-induced rat model of Parkinson\u2019s disease","volume":"13","author":"Wang","year":"2017","journal-title":"Mol. Pain"},{"issue":"2","key":"10.1016\/j.pnpbp.2026.111848_bb0705","doi-asserted-by":"crossref","first-page":"807","DOI":"10.3233\/JAD-200401","article-title":"Escitalopram alleviates Alzheimer\u2019s disease-type tau pathologies in the aged P301L tau transgenic mice","volume":"77","author":"Wang","year":"2020","journal-title":"J. Alzheimer\u2019s Dis"},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111848_bb0710","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41392-020-00443-w","article-title":"Metabolism pathways of arachidonic acids: mechanisms and potential therapeutic targets","volume":"6","author":"Wang","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"issue":"4","key":"10.1016\/j.pnpbp.2026.111848_bb0715","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1177\/1073858421991066","article-title":"Neuroinflammation in Parkinson\u2019s disease: triggers, mechanisms, and immunotherapies","volume":"28","author":"Wang","year":"2022","journal-title":"Neuroscientist"},{"issue":"12","key":"10.1016\/j.pnpbp.2026.111848_bb0720","doi-asserted-by":"crossref","first-page":"8341","DOI":"10.1039\/D2CP05676C","article-title":"A multiple-step screening protocol to identify norepinephrine and dopamine reuptake inhibitors for depression","volume":"25","author":"Wang","year":"2023","journal-title":"Phys. Chem. Chem. Phys."},{"issue":"1\u20133","key":"10.1016\/j.pnpbp.2026.111848_bb0725","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.cbi.2008.05.038","article-title":"The neuroprotective effect of ladostigil against hydrogen peroxide-mediated cytotoxicity","volume":"175","author":"Weinreb","year":"2008","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.pnpbp.2026.111848_bb0730","series-title":"Does 1-(R)-aminoindan Possess Neuroprotective Properties Against Experimental Parkinson\u2019s Disease?","author":"Weinreb","year":"2011"},{"issue":"6","key":"10.1016\/j.pnpbp.2026.111848_bb0735","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0252969","article-title":"Aspirin using was associated with slower cognitive decline in patients with Alzheimer's disease","volume":"16","author":"Weng","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.pnpbp.2026.111848_bb0740","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1161850","article-title":"Revisiting the neuroinflammation hypothesis in Alzheimer\u2019s disease: a focus on the druggability of current targets","volume":"14","author":"Wong-Guerra","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.pnpbp.2026.111848_bb0745","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0014-2999(93)90181-G","article-title":"Apparent antioxidant effect of l-deprenyl on hydroxyl radical formation and nigral injury elicited by MPP+ in vivo","volume":"243","author":"Wu","year":"1993","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2026.111848_bb0750","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.neurobiolaging.2018.03.011","article-title":"Escitalopram alleviates stress-induced Alzheimer\u2019s disease-like tau pathologies and cognitive deficits by reducing hypothalamic-pituitary-adrenal axis reactivity and insulin\/GSK-3\u03b2 signal pathway activity","volume":"67","author":"Wu","year":"2018","journal-title":"Neurobiol. Aging"},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111848_bb0755","doi-asserted-by":"crossref","first-page":"365","DOI":"10.3233\/ADR-200218","article-title":"Neurogenesis makes a crucial contribution to the neuropathology of Alzheimer\u2019s disease","volume":"4","author":"Young","year":"2020","journal-title":"J. Alzheimers Dis. Rep."},{"key":"10.1016\/j.pnpbp.2026.111848_bb0760","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.872134","article-title":"The emerging role of central and peripheral immune systems in neurodegenerative diseases","volume":"14","author":"Zang","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.pnpbp.2026.111848_bb0765","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.neuroscience.2016.11.004","article-title":"Genome-wide pathway-based association analysis identifies risk pathways associated with Parkinson's disease","volume":"340","author":"Zhang","year":"2017","journal-title":"Neuroscience"},{"key":"10.1016\/j.pnpbp.2026.111848_bb0770","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109417","article-title":"Fluoxetine shows neuroprotective effects against LPS-induced neuroinflammation via the notch signaling pathway","volume":"113","author":"Zhang","year":"2022","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111848_bb0775","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/s41392-023-01486-5","article-title":"Role of neuroinflammation in neurodegeneration development","volume":"8","author":"Zhang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111848_bb0780","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s12883-023-03191-w","article-title":"A systematic review and meta-analysis on the efficacy outcomes of selective serotonin reuptake inhibitors in depression in Alzheimer\u2019s disease","volume":"23","author":"Zhang","year":"2023","journal-title":"BMC Neurol."},{"issue":"5","key":"10.1016\/j.pnpbp.2026.111848_bb0785","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1111\/j.1471-4159.2008.05330.x","article-title":"Comparison of neuroprotective and neurorestorative capabilities of rasagiline and selegiline against lactacystin-induced nigrostriatal dopaminergic degeneration","volume":"105","author":"Zhu","year":"2008","journal-title":"J. Neurochem."}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584626002460?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584626002460?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:45:46Z","timestamp":1790714746000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584626002460"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":157,"alternative-id":["S0278584626002460"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2026.111848","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unlocking new uses: The promise of antidepressants in treating Alzheimer's and Parkinson's through Neuroinflammation modulation","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2026.111848","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"111848"}}